Characteristics | Low expression of MTF1 | High expression of MTF1 | P value |
---|---|---|---|
n | 269 | 270 | |
Pathologic T stage, n (%) | 0.644 | ||
T1 | 83 (15.5%) | 93 (17.4%) | |
T2 | 148 (27.6%) | 144 (26.9%) | |
T3 | 28 (5.2%) | 21 (3.9%) | |
T4 | 10 (1.9%) | 9 (1.7%) | |
Pathologic N stage, n (%) | 0.458 | ||
N0 | 177 (33.8%) | 173 (33.1%) | |
N1 | 54 (10.3%) | 43 (8.2%) | |
N2 | 32 (6.1%) | 42 (8%) | |
N3 | 1 (0.2%) | 1 (0.2%) | |
Age, median (IQR) | 66 (58, 73) | 66 (60, 72) | 0.641 |
Gender, n (%) | 0.577 | ||
Female | 141 (26.2%) | 148 (27.5%) | |
Male | 128 (23.7%) | 122 (22.6%) | |
Pathologic stage, n (%) | 0.873 | ||
I 期 | 147 (27.7%) | 149 (28.1%) | |
II 期 | 64 (12.1%) | 61 (11.5%) | |
III 期 | 41 (7.7%) | 43 (8.1%) | |
IV 期 | 11 (2.1%) | 15 (2.8%) |